Sophiris Bio Inc fka SPHS

[Maple tree]

I bought sphs when it was less than 50 cents a few years ago, and unloaded half of position around $2.5 later. Now it is a waiting period. Another promising prostate cancer stock, obmp, just released good phase1 data and company is ready for phase2 at Harvard pending for FDA approval. SP is about dime now or MC is less than $20 millions, and could go much higher in next few months. Check it and do your DD.